The Archive · 3 posts
Innovating skin health! 🌟 SkinBioTherapeutics PLC (SBTX) leads the way in skin care sciences with groundbreaking biotechnologies. 🧬
SkinBioTherapeutics restates FY25 results after board investigation finds fabricated revenue. Cash intact but governance overhaul needed. Key investor takeaways.
June 8, 2026
Showing 2 of 3 posts
SkinBioTherapeutics' FY25: 284% revenue surge driven by first Croda royalties and Superdrug retail launch.
JoshuaDecember 5, 2025
SkinBioTherapeutics quadruples FY25 revenue to £4.5m-£4.8m, nears EBITDA profitability, and prepares for transformative Superdrug Autumn launch.
JoshuaAugust 14, 2025